StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
VIMAB.ST$2.81-0.34%
Fair $2.81+0.0%

VIMAB.ST

Vimab Group AB (publ)

Industrials / Consulting ServicesStockholm

$2.81

-0.01 (-0.34%)

Fairly Valued+0.0%Fair Value $2.81Fund rank 24/100 · Data gapFallback financials|
SA 20/D
F-Score: 2/9
Declining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-8.1M · quality 36.0/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

20/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 2unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years ROE is -2.8%, below the 5% threshold
Thesis & Journal · VIMAB.STLocal privado en este navegador · Vimab Group AB (publ)
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$134M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-281.5%

↓

Gross Margin

69.4%

↑

Debt/Equity

0.95

↑
52-Week Range$3
$2$9

TradingView lightweight chart

VIMAB.ST price, volumen y niveles de valoración

Último $2.900Periodo -91.3%
Fair value: $2.810

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+11.7%

FCF CAGR

—

FCF margin

-8.9%

FCF / Net income

0.28x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $313.4M · net income $-101.7M · FCF $-28.0M

2022-FY → 2025-FY

Gross margin

69.4%-5.1% pts

Operating margin

-20.7%-14.9% pts

Net margin

-32.4%-17.2% pts

FCF margin

-8.9%-8.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$313.4M$313.4M$323.6M$341.6M$224.8M
Net Income$-101.7M$-101.7M$-76.9M$-4.3M$-34.2M
EBITDA$-37.7M$-37.7M$-14.9M$29.1M$-8.6M
EPS-3.90-3.90-3.30-0.30-1.60
Gross Margin69.4%69.4%78.5%68.6%74.5%
Operating Margin-20.7%-20.7%-24.6%0.5%-5.9%
Net Margin-32.4%-32.4%-23.8%-1.2%-15.2%
Balance Sheet
Debt/Equity0.950.954.721.321.02
Current Ratio0.710.71———
Cash Flow
Free Cash Flow$-28.0M$-28.0M$-8.1M$152000.00$-1.2M
Returns
ROE-281.5%-281.5%-433.6%-5.4%-60.2%
Valuation
EV/EBITDA———8.58—
P/B2.032.0315.602.241.52
Growth & Yield
Revenue Growth-3.1%-3.1%-5.3%51.9%—
EPS Growth-18.2%-18.2%-1000.0%81.3%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -63.3%

Total return

-63.3%

Start / end P/E

n/dx → n/dx

EPS bridge

-3.30 → -3.90

Residual

-63.3%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-63.3%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.